Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
17.45x3.2x-4.85x2.94x9.1x8.9x-.--% 21.54B
15.83x1.84x-2.3x3.42x9.23x10.1x0.64% 62.21B
29.23x4.36x2.24x5.92x17.17x21.86x0.54% 59.45B
31.79x6.41x0.61x10.74x20.27x23.99x-.--% 38.9B
-48.35x2.2x0.39x2.94x8.68x10.12x3.8% 36.4B
32.29x1.49x-1.09x3.5x10.56x12.43x-.--% 29.52B
-5.74x3.38x-0.3x7.71x-4.71x-4.47x-.--% 19.7B
46.9x4.67x0.25x4.95x35.54x32.38x-.--% 16.18B
24.54x3.43x0.02x5.08x13.7x19.07x-.--% 15.89B
-31.05x-5.39x0.73x14.64x-44.34x-46.1x-.--% 13.23B
-131.25x13441.21x2.77x13.14x-116.42x-131.36x-.--% 13.06B
63.49x26.03x0.6x39.78x55.88x57.52x0.15% 12.15B
15.77x - 0.16x3.4x12.46x14.93x-.--% 10.74B
41.25x - 2.95x - - - -.--% 9.48B
11.64x1.01x0.41x1.8x7.26x9.67x2.89% 6.23B
-109.91x - 7.28x - - - -.--% 5.4B
12.78x1.19x-0.19x2.17x5.61x6.75x1.75% 5.18B
52.83x3.73x-0.68x - - - - 5.01B
24.02x - 1.18x6.35x16.85x20.12x0.43% 4.9B
Average 4.92x 899.92x 0.54x 8.03x 3.55x 4.12x 0.57% 20.27B
Weighted average by Cap. 9.60x 498.57x 0.04x 6.87x 7.58x 8.91x 0.64%
Biopharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!